UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024837
Receipt number R000028582
Scientific Title The relationship between intestinal microbioma and liver disease by direct collecing portal venous blood
Date of disclosure of the study information 2016/11/15
Last modified on 2022/05/23 15:18:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The relationship between intestinal microbioma and liver disease by direct collecing portal venous blood

Acronym

The relationship between intestinal microbioma and liver disease by direct collecing portal venous blood

Scientific Title

The relationship between intestinal microbioma and liver disease by direct collecing portal venous blood

Scientific Title:Acronym

The relationship between intestinal microbioma and liver disease by direct collecing portal venous blood

Region

Japan


Condition

Condition

liver disease

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the relationship between liver disease and intestinal microbiota.

Basic objectives2

Others

Basic objectives -Others

To evaluate bactrerial featrure in the portal venous blood and stool.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To identify the microbiota collerated with liver disease.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

liver disease,liver cirrhosis
non-cirrhotic portal hypertension
(idiopatic potral hypertension, oxaliptatin induced sinusiodal obstraction syndrome, etc)

Key exclusion criteria

1.Patients with severe heart, kedney and liver disease.
2.Patients with allergy of contrast agent
3.Patients during pregnancy

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Tsunamasa
Middle name
Last name Watanabe

Organization

St.Marianna University school of Medicine

Division name

Division of Gastroenterology and Hepatology

Zip code

216-8511

Address

Kanagawa, Kawasaki 216-8511, Japan

TEL

044-977-8111

Email

twatanab@marianna-u.ac.jp


Public contact

Name of contact person

1st name Ryuta
Middle name
Last name Shigefuku

Organization

St.Marianna University school of Medicine

Division name

Division of Gastroenterology and Hepatology

Zip code

216-8511

Address

Kanagawa, Kawasaki 216-8511, Japan

TEL

044-977-8111

Homepage URL


Email

r2shigefuku@marianna-u.ac.jp


Sponsor or person

Institute

St.Marianna University school of Medicine

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Reseach

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

St.Marianna University school of Medicine

Address

Kanagawa, Kawasaki 216-8511, Japan

Tel

044-977-8111

Email

twatanab@marianna-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

28

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 07 Month 04 Day

Date of IRB

2016 Year 07 Month 04 Day

Anticipated trial start date

2016 Year 07 Month 04 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2016 Year 11 Month 15 Day

Last modified on

2022 Year 05 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028582


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name